Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Aeterna Zentaris bottoms out after a stinging FDA rejection
Fierce Biotech
Friday, November 7, 2014 - 10:15am
tags:
Aeterna Zentaris, FDA, macimorelin
Why AbbVie Inc.'s Game-Changing New Drug Could Be a Serious Threat to Gilead Sciences Inc.
Motley Fool
Friday, November 7, 2014 - 10:11am
tags:
AbbVie, Gilead Sciences, Enanta, Harvoni, hepatitis C
Allergan Should Run an Auction, Hostile Hedge Fund Says
Bloomberg
Friday, November 7, 2014 - 10:05am
tags:
Allergan, M&A
DOJ interested in Impax Labs paper trail
Seeking Alpha
Friday, November 7, 2014 - 9:04am
tags:
Impax Labs, DOJ
Isis beats 3Q profit forecasts
Yahoo/AP
Friday, November 7, 2014 - 8:52am
tags:
Isis Pharmaceuticals, earnings
[video] Treat Sickness as Biodefense Threat: GlaxoSmithKline CEO
Bloomberg
Friday, November 7, 2014 - 8:49am
tags:
GSK, biodefense drugs, Andrew Witty
Rockwell Dialysis Therapy Wins Panel Support But Final FDA Approval? Not So Fast.
TheStreet.com
Friday, November 7, 2014 - 8:48am
tags:
Rockwell Medical, dialysis, FDA, advisory panels, devices
UCB to Sell U.S. Generic Unit to Advent, Avista Capital
Bloomberg
Friday, November 7, 2014 - 7:48am
tags:
UCB Pharmaceuticals, M&A, generics, Advent International, Avista Capital
GlaxoSmithKline's effort to relaunch cancer R&D faces skepticism
Bloomberg
Friday, November 7, 2014 - 7:44am
tags:
GSK, R&D
Ranbaxy Drops as FDA Withdraws Tentative Approval For Two Drugs
Bloomberg
Friday, November 7, 2014 - 7:41am
tags:
Ranbaxy, FDA, generics, Sun Pharma, Valcyte, Nexium
Allergan Tussle Plumps Up Botox Maker’s Price: Real M&A
Bloomberg
Friday, November 7, 2014 - 7:39am
tags:
Allergan, M&A, Valeant Pharmaceuticals, Actavis
Salix Pharma Plunges 38% Late On Earnings Miss, Audit Probe
Yahoo/Investors Business Daily
Friday, November 7, 2014 - 7:36am
tags:
Salix, earnings
Intercept misses 3Q profit forecasts
Yahoo/AP
Friday, November 7, 2014 - 7:35am
tags:
Intercept Pharma, earnings
Will Pfizer Sweeten Its Bid For AstraZeneca?
Investors.com
Thursday, November 6, 2014 - 7:31pm
tags:
Pfizer, AstraZeneca, M&A
Intercept Liver Drug Needs Safety Review, Researchers Say
Bloomberg
Thursday, November 6, 2014 - 7:30pm
tags:
Intercept Pharma, OCA
Zogenix beats Street 3Q forecasts
Yahoo/AP
Thursday, November 6, 2014 - 7:29pm
tags:
Zogenix, earnings
Neurocrine Biosciences Looking Forward To A Big Year
Seeking Alpha
Thursday, November 6, 2014 - 2:57pm
tags:
Neurocrine Biosciences
Myriad Genetics Down on Earnings, Revenue Miss in Q1
Yahoo/Zacks.com
Thursday, November 6, 2014 - 2:54pm
tags:
Myriad Genetics, earnings
Sanofi, armed with more strong PhIII dengue data, sets sights on 2015 rollout
Fierce Vaccines
Thursday, November 6, 2014 - 11:44am
tags:
Sanofi, dengue, vaccines
Oops! Did FDA Mistakenly Give Ranbaxy Approval to Sell Generic Nexium?
WSJ Pharmalot
Thursday, November 6, 2014 - 10:57am
tags:
FDA, generics, AstraZeneca, Nexium, Ranbaxy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.